Regression of S-180 sarcoma using a xenogeneic antiserum.
Indian J Exp Biol
;
1991 Apr; 29(4): 393-5
Article
Dans Anglais
| IMSEAR
| ID: sea-61379
ABSTRACT
Tumour angiogenesis factor (TAF) was extracted from S-180 sarcoma grown as a solid tumour in Swiss albino mice. Its angiogenic activity was detected using the mouse intradermal and the chick chorioallantois membrane assays. Similar extracts from normal tissues failed to induce neovascularisation. An antiserum raised in rabbit, against TAF purified from mouse mammary adenocarcinoma was shown to neutralise the biological activity of TAF from S-180 sarcoma and also caused tumour regression in the mice. A possible therapeutic approach to solid tumours is indicated, as also the preparation of an immunotoxin.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Sarcome 180 de Crocker
/
Agents angiogéniques
/
Immunothérapie
/
Animaux
/
Anticorps
langue:
Anglais
Texte intégral:
Indian J Exp Biol
Année:
1991
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS